These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 23585468)

  • 1. Double-blind, controlled, clinical trial planned in germany to investigate the efficacy of psychotherapy combined with triptorelin in adult male patients with severe pedophilic disorders: presentation of the study protocol.
    Briken P; Berner W;
    Isr J Psychiatry Relat Sci; 2012; 49(4):306-13. PubMed ID: 23585468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review.
    Turner D; Briken P
    J Sex Med; 2018 Jan; 15(1):77-93. PubMed ID: 29289377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug treatment of paraphilic and nonparaphilic sexual disorders.
    Guay DR
    Clin Ther; 2009 Jan; 31(1):1-31. PubMed ID: 19243704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of a new law for sex offenders implemented in France in 1998].
    Tesson J; Cordier B; Thibaut F
    Encephale; 2012 Apr; 38(2):133-40. PubMed ID: 22516271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review.
    Briken P; Hill A; Berner W
    J Clin Psychiatry; 2003 Aug; 64(8):890-7. PubMed ID: 12927003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Failure of a study in forensic psychiatric hospitals : Clinical trial to investigate the additive effect of triptorelin on the efficacy of psychotherapy].
    Briken P; Müller JL; Berner W; Bödeker RH; Vollmann J; Kasperk C; Koller M
    Nervenarzt; 2017 May; 88(5):480-485. PubMed ID: 28289788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription of testosterone-lowering medications for sex offender treatment in German forensic-psychiatric institutions.
    Turner D; Basdekis-Jozsa R; Briken P
    J Sex Med; 2013 Feb; 10(2):570-8. PubMed ID: 23088739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a long-lasting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia.
    Thibaut F; Cordier B; Kuhn JM
    Acta Psychiatr Scand; 1993 Jun; 87(6):445-50. PubMed ID: 8356897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone.
    Rösler A; Witztum E
    N Engl J Med; 1998 Feb; 338(7):416-22. PubMed ID: 9459644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen deprivation therapy of self-identifying, help-seeking pedophiles in the Dunkelfeld.
    Amelung T; Kuhle LF; Konrad A; Pauls A; Beier KM
    Int J Law Psychiatry; 2012; 35(3):176-84. PubMed ID: 22420933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The German Dunkelfeld project: a pilot study to prevent child sexual abuse and the use of child abusive images.
    Beier KM; Grundmann D; Kuhle LF; Scherner G; Konrad A; Amelung T
    J Sex Med; 2015 Feb; 12(2):529-42. PubMed ID: 25471337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood sexual victimization, pedophilic interest, and sexual recidivism.
    Nunes KL; Hermann CA; Renee Malcom J; Lavoie K
    Child Abuse Negl; 2013 Sep; 37(9):703-11. PubMed ID: 23517571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leuprolide acetate suppresses pedophilic urges and arousability.
    Schober JM; Kuhn PJ; Kovacs PG; Earle JH; Byrne PM; Fries RA
    Arch Sex Behav; 2005 Dec; 34(6):691-705. PubMed ID: 16362253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Injunction to care. Results of a study carried out in the regions of Alsace and Lorraine].
    Halleguen O; Baratta A
    Encephale; 2014 Feb; 40(1):42-7. PubMed ID: 23351931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged flare-up of testosterone after administration of a gonadotrophin agonist to a sex offender: an under-recognised risk?
    Huygh J; Verhaegen A; Goethals K; Cosyns P; De Block C; Van Gaal L
    Crim Behav Ment Health; 2015 Jul; 25(3):226-30. PubMed ID: 25851640
    [No Abstract]   [Full Text] [Related]  

  • 16. Measuring Pedophilic Sexual Interest.
    Carvalho J; Bradford J; Murphy L; Briken P; Fedoroff P
    J Sex Med; 2020 Mar; 17(3):378-392. PubMed ID: 31932255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric comorbidity in pedophilic sex offenders.
    Raymond NC; Coleman E; Ohlerking F; Christenson GA; Miner M
    Am J Psychiatry; 1999 May; 156(5):786-8. PubMed ID: 10327918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of sex offenders with antiandrogenic medication: conceptualization, review of treatment modalities, and preliminary findings.
    Berlin FS; Meinecke CF
    Am J Psychiatry; 1981 May; 138(5):601-7. PubMed ID: 6453535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of testosterone in sexuality and paraphilia--a neurobiological approach. Part II: testosterone and paraphilia.
    Jordan K; Fromberger P; Stolpmann G; Müller JL
    J Sex Med; 2011 Nov; 8(11):3008-29. PubMed ID: 21797985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses.
    Sauter J; Turner D; Briken P; Rettenberger M
    Sex Abuse; 2021 Jun; 33(4):475-500. PubMed ID: 32167420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.